Cargando…

Cognitive Deficits as a Mediator of Poor Occupational Function in Remitted Major Depressive Disorder Patients

Cognitive deficits in major depressive disorder (MDD) patients have been described in numerous studies. However, few reports have aimed to describe cognitive deficits in the remitted state of MDD and the mediational effect of cognitive deficits on occupational outcome. The aim of the current review...

Descripción completa

Detalles Bibliográficos
Autores principales:	Woo, Young Sup, Rosenblat, Joshua D., Kakar, Ron, Bahk, Won-Myong, McIntyre, Roger S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730927/ https://www.ncbi.nlm.nih.gov/pubmed/26792035 http://dx.doi.org/10.9758/cpn.2016.14.1.1

Ejemplares similares

The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Rosenblat, Joshua D, et al.
Publicado: (2015)

Obesity and Its Potential Effects on Antidepressant Treatment Outcomes in Patients with Depressive Disorders: A Literature Review
por: Woo, Young Sup, et al.
Publicado: (2016)

Pharmacological Treatment of Major Depressive Episodes with Mixed Features: A Systematic Review
por: Shim, In Hee, et al.
Publicado: (2018)

An App-Based Digit Symbol Substitution Test for Assessment of Cognitive Deficits in Adults With Major Depressive Disorder: Evaluation Study
por: McIntyre, Roger S, et al.
Publicado: (2022)

Abnormal Cerebellar Volume in Patients with Remitted Major Depression with Persistent Cognitive Deficits
por: Depping, Malte S., et al.
Publicado: (2020)

The Diagnostic Stability of DSM-IV Diagnoses: An Examination of Major Depressive Disorder, Bipolar I Disorder, and Schizophrenia in Korean Patients
por: Kim, Won, et al.
Publicado: (2011)

Correction to: Abnormal Cerebellar Volume in Patients with Remitted Major Depression with Persistent Cognitive Deficits
por: Depping, Malte S., et al.
Publicado: (2021)

Bipolar Disorder and Immune Dysfunction: Epidemiological Findings, Proposed Pathophysiology and Clinical Implications
por: Rosenblat, Joshua D., et al.
Publicado: (2017)

The THINC-it Tool for Cognitive Assessment and Measurement in Major Depressive Disorder: Sensitivity to Change
por: McIntyre, Roger S., et al.
Publicado: (2020)

Cortical Shape and Curvedness Analysis of Structural Deficits in Remitting and Non-Remitting Depression
por: Liao, Yuan-Lin, et al.
Publicado: (2013)

PS106. Nicotinic acetylcholine receptor antagonists for treatment-resistant depression: A meta-analysis.
por: Wang, Hee Ryung, et al.
Publicado: (2016)

Rapid Onset of Intranasal Esketamine in Patients with Treatment Resistant Depression and Major Depression with Suicide Ideation: A Meta-Analysis
por: Wang, Sheng-Min, et al.
Publicado: (2021)

PS150. Comparative efficacy of various augmentation strategies for treatment-resistant depression: a meta-analysis of randomized controlled trials
por: Wang, Hee Ryung, et al.
Publicado: (2016)

Comparison between Atomoxetine and OROS Methylphenidate as an Adjunctive to SSRIs in Attention-deficit/Hyperactivity Disorder Adults with Comorbid Partially Responsive Major Depressive Disorder: A Head-to-head, 12-week, Randomized, Rater-blinded Clinical Trial
por: Shim, Se-hoon, et al.
Publicado: (2022)

Antidepressants and Mood Stabilizers: Novel Research Avenues and Clinical Insights for Bipolar Depression
por: Shim, In Hee, et al.
Publicado: (2017)

Cognitive deficits, depressive symptoms, insight, and medication adherence in remitted patients with schizophrenia
por: Settem, V. V. Jagadeesh, et al.
Publicado: (2019)

Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review
por: Rosenblat, Christian, et al.
Publicado: (2015)

Changes in insulin resistance following antidepressant treatment mediate response in major depressive disorder
por: Rashidian, Houman, et al.
Publicado: (2022)

Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder
por: Rong, Carola, et al.
Publicado: (2018)

Clinical Evidence of Antidepressant Effects of Insulin and Anti-Hyperglycemic Agents and Implications for the Pathophysiology of Depression—A Literature Review
por: Woo, Young Sup, et al.
Publicado: (2020)

Neurocognitive deficits in depression: a systematic review of cognitive impairment in the acute and remitted state
por: Kriesche, Dominik, et al.
Publicado: (2022)

Emotion Differentiation in Current and Remitted Major Depressive Disorder
por: Thompson, Renee J., et al.
Publicado: (2021)

Amisulpride Augmentation in Schizophrenia Patients with Poor Response to Olanzapine: A 4-week, Randomized, Rater-Blind, Controlled, Pilot Study
por: Woo, Young Sup, et al.
Publicado: (2022)

Paroxetine versus Venlafaxine and Escitalopram in Korean Patients with Major Depressive Disorder: A Randomized, Rater-blinded, Six-week Study
por: Woo, Young Sup, et al.
Publicado: (2017)

A review of electroencephalographic changes in diabetes mellitus in relation to major depressive disorder
por: Baskaran, Anusha, et al.
Publicado: (2013)

Vitamin D Deficiency/Insufficiency among Inpatients with Depressive Symptoms
por: Woo, Young Sup, et al.
Publicado: (2019)

Increased Amygdala Response to Shame in Remitted Major Depressive Disorder
por: Pulcu, Erdem, et al.
Publicado: (2014)

Additional Reduction of Residual Symptoms with Aripiprazole Augmentation in the Patients with Partially Remitted Major Depressive Disorder
por: Shin, Cheolmin, et al.
Publicado: (2021)

The Relationship between Plasma Erythropoietin Levels and Symptoms of Attention Deficit Hyperactivity Disorder
por: Shim, Se-hoon, et al.
Publicado: (2021)

Lurasidone as a potential therapy for bipolar disorder
por: Woo, Young Sup, et al.
Publicado: (2013)

Ginkgo biloba induced mood dysregulation: a case report
por: Rho, Seung Sun, et al.
Publicado: (2018)

Naltrexone-associated Visual Hallucinations: A Case Report
por: Lee, Dae Bo, et al.
Publicado: (2019)

Symptom severity of depressive symptoms impacts on social cognition performance in current but not remitted major depressive disorder
por: Air, Tracy, et al.
Publicado: (2015)

The measurement of cognitive reactivity to sad mood in patients remitted from major depressive disorder
por: Figueroa, Caroline A., et al.
Publicado: (2018)

Effectiveness and Tolerability of Korean Red Ginseng Augmentation in Major Depressive Disorder Patients with Difficult-to-treat in Routine Practice
por: Lee, Kyung Ho, et al.
Publicado: (2020)

Efficacy and safety of generic escitalopram (Lexacure(®)) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded, escitalopram-comparative, non-inferiority study
por: Jeong, Jong-Hyun, et al.
Publicado: (2015)

Efficacy and Tolerability of Generic Mirtazapine (Mirtax) for Major Depressive Disorder: Multicenter, Open-label, Uncontrolled, Prospective Study
por: Song, Hoo Rim, et al.
Publicado: (2015)

Onset and frequency of depression in post-COVID-19 syndrome: A systematic review
por: Renaud-Charest, Olivier, et al.
Publicado: (2021)

The efficacy and safety of bupropion sustained-release formulation for the treatment of major depressive disorder: a multi-center, randomized, double-blind, placebo-controlled study in Asian patients
por: Koshino, Yoshifumi, et al.
Publicado: (2013)

Real-World Determinants of Adjunctive Antipsychotic Prescribing for Patients with Major Depressive Disorder and Inadequate Response to Antidepressants: A Case Review Study
por: McIntyre, Roger S., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_oglphk037m3e67i7bsq724baga